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Abstract
Height is the result of many growth and development processes. Most of the genes associ-
ated with height are known to play a role in skeletal development. Single-nucleotide poly-
morphisms in the SPAG17 gene have been associated with human height. However, it is
not clear how this gene influences linear growth. Here we show that a targeted mutation in
Spag17 leads to skeletal malformations. Hind limb length in mutants was significantly
shorter than in wild-type mice. Studies revealed differences in maturation of femur and tibia
suggesting alterations in limb patterning. Morphometric studies showed increased bone for-
mation evidenced by increased trabecular bone area and the ratio of bone area to total
area, leading to reductions in the ratio of marrow area/total area in the femur. Micro-CTs
and von Kossa staining demonstrated increased mineral in the femur. Moreover, osteocal-
cin and osterix were more highly expressed in mutant mice than in wild-type mice femurs.
These data suggest that femur bone shortening may be due to premature ossification. On
the other hand, tibias appear to be shorter due to a delay in cartilage and bone develop-
ment. Morphometric studies showed reduction in growth plate and bone formation. These
defects did not affect bone mineralization, although the volume of primary bone and levels
of osteocalcin and osterix were higher. Other skeletal malformations were observed includ-
ing fused sternebrae, reduced mineralization in the skull, medial and metacarpal phalanges.
Primary cilia from chondrocytes, osteoblasts, and embryonic fibroblasts (MEFs) isolated
from knockout mice were shorter and fewer cells had primary cilia in comparison to cells
from wild-type mice. In addition, Spag17 knockdown in wild-type MEFs by Spag17 siRNA
duplex reproduced the shorter primary cilia phenotype. Our findings disclosed unexpected
functions for Spag17 in the regulation of skeletal growth and mineralization, perhaps be-
cause of its role in primary cilia of chondrocytes and osteoblasts.
PLOS ONE | DOI:10.1371/journal.pone.0125936 May 27, 2015 1 / 16
OPEN ACCESS
Citation: Teves ME, Sundaresan G, Cohen DJ, Hyzy
SL, Kajan I, Maczis M, et al. (2015) Spag17
Deficiency Results in Skeletal Malformations and
Bone Abnormalities. PLoS ONE 10(5): e0125936.
doi:10.1371/journal.pone.0125936
Academic Editor: Luc Malaval, Université de Lyon—
Université Jean Monnet, FRANCE
Received: January 5, 2015
Accepted: March 25, 2015
Published: May 27, 2015
Copyright: © 2015 Teves et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: This work was supported by National
Institutes of Health [grant number R01 HD-37416 to
J.F.S., R01 HD-076257 to Z.Z.]. The funders had no
role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
Introduction
Human height is a highly heritable, classic polygenic trait [1]. Genetic alterations affecting
height variation provide insight into human growth and development, as well as the genetic ar-
chitecture of a number of diseases [2]. Prenatal longitudinal bone development and growth is a
determinant of an individual’s postnatal height [3]. After formation of the cartilage anlage, lon-
gitudinal growth occurs at the epiphyseal growth plate, a layer of cartilage cells that are ar-
ranged in columns between epiphyseal and metaphyseal bone present in long bones and
scapulae. In normal fetal growth plates, immature chondrocytes are located in a reserve cell
zone (resting zone) that is oriented toward the epiphysis. Under hormonal, growth factor and
mechanical regulation, these cells proliferate (proliferating cell zone), which increases length of
the bone. After a set number of divisions, the cells undergo hypertrophy, remodeling their ex-
tracellular matrix to accommodate the change in cell shape (hypertrophic cell zone). Finally,
the chondrocytes mineralize their extracellular matrix (calcifying cell zone), which is then vas-
cularized, leading to bone formation [4]. In addition to long bone growth in the fetus, the di-
aphyseal bone also undergoes development with cortical bone forming around the cartilage
anlage as the core is replaced with marrow [5,6].
Several genes have been shown to be involved in height [1,2,7–12], including those encoding
proteins that are involved in signaling pathways known to be important in skeletal growth and
development. Interestingly, single-nucleotide polymorphisms (SNPs) in the sperm associated
antigen 17 protein gene (SPAG17) have been associated with human height [1,7,9–13] and idi-
opathic short stature in a Korean population [2]. However, it is not clear whether this gene di-
rectly influences height and/or skeletal growth.
Spag17 encodes a protein present in cilia and flagella with a “9+2” axoneme structure.
SPAG17 protein is present in the central pair complex (CPC). It is the orthologue of Chlamydo-
monas reinhardtii PF6 [14], a protein located on a projection from the C1 CPC microtubule in
green algae [15]. Domains near the C-terminus of PF6 are essential for flagellar motility and as-
sembly of the C1a projection. The N-terminal half is not required for the assembly, but it is im-
portant for stability of C1a complex members [16].
PF6 protein interacts with a number of other proteins, including calmodulin [17]. Conse-
quently, PF6 is thought to be a proximal effector of CPC action on the sliding activity of the
outer doublets that control cilia or flagellar beat. Chlamydomonas pf6mutants have paralyzed
flagella, and lack the CPC 1a projection [15].
The murine Spag17 gene encodes a full-length 250 kDa protein found in testis and tissues
with motile cilia, but other splice variants and proteolytically generated fragments have been
described [14,18]. Targeting of Spag17 resulted in a severe phenotype characterized by motile
cilia dysfunction in the nares and trachea, reduced clearance of nasal mucus, profound respira-
tory distress associated with lung fluid accumulation and disruption of the alveolar epithelium,
cerebral ventricular expansion consistent with emerging hydrocephalus, failure to suckle, and
neonatal demise within 12 h of birth. Ultrastructural analysis revealed loss of one CPC micro-
tubule in approximately one quarter of tracheal cilia axonemes, absence of a C1 microtubule
projection, as well as less frequent CPC structural abnormalities [19].
In the present study, the effect of a targeted mutation in Spag17 on the skeleton during dif-
ferentiation, maturation and growth was examined. The effect of silencing of Spag17-/- on oste-
oblasts and chondrocytes was examined to evaluate the role of Spag17 in cells involved in
osteochondral development. Our findings suggest that SPAG17 protein plays a role in endo-
chondral bone formation, most likely because of a function in primary cilia.
Spag17 and Skeletal Development
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Results
Spag17 plays a role in skeletal development
Spag17-/- mice have a severe phenotype characterized by motile cilia dysfunction [19]. Here we
show that Spag17-/- mice also have skeletal malformations. This finding was verified using a va-
riety of experimental methods and provides evidence for a functional role for SPAG17 in
height, consistent with multiple genetic association studies.
Spag17-deficient mice exhibit defects in development of the femur. Because SPAG17
has been associated with human height [1,7,9–13], we investigated hind limb length. Femurs
and tibias from wild-type and mutant mice were isolated, stained with Alcian blue and Alizarin
red for cartilage and bone detection, respectively, and then length was measured as described
in Materials and Methods. Fig 1A shows that femurs from mutant mice are significantly
shorter than wild-type mice. However, no differences in bone width were observed.
Fig 1. Femur bone development is affected in Spag17-deficient mice. (A) Alcian Blue/ Alizarin Red staining of femur from wild-type (+/+) and Spag17-
mutant (-/-) mice. Measurement of femur length and calcified femur bone length shows Spag17-mutant limbs are shorter than wild-type mice. Scale bars, 0.5
mm. (B) Histological and morphometric studies on femur shows increase bone formation in mutant mice. Scale bars, 200 μm. (C) von Kossa staining reveals
increased calcification in mutant mice. (D) Micro-CT structural analysis on femurs; mid-sagittal sections (left) and cross-sectional trans-axial views at the mid-
diaphysis (right). Images were acquired in 600 projections in 180 degrees of rotation with 500 miliseconds exposure per projection. Scale bars, 200 μm. (E)
mRNA expression of osterix (Osx) and osteocalcin (Ocn) measured by qPCR. (+/+), wild-type; (-/-), Spag17-mutant mice. Data are presented as
means ± SEM from7 mice. * Indicates statistically significant differences, p< 0.05. hz: hypertrophic zone; BA/TA: bone area/total area; MA/TA: marrow
area/total area; BV/TV: bone volume/total volume;Osx: osterix;Ocn: osteocalcin.
doi:10.1371/journal.pone.0125936.g001
Spag17 and Skeletal Development
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Morphometric studies showed normal cartilage development without significant differences in
the growth plate area and number of cells in the hypertrophic zone. Trabecular bone area and
bone area/total area were increased, leading to a reduction in marrow area/total area in the mu-
tant mice (Fig 1B and S1 Fig). Because bone formation is related to bone mineralization, we ex-
amined the mineral deposits by von Kossa staining. This analysis revealed significant
differences indicating that the Spag17mutation has a significant effect on mineral deposition
within the bone matrix (Fig 1C and S1 Fig). Increases in the ratio of BV/TV(%) were also ob-
served by micro-CT scanning (Fig 1D). In addition, the expression of two genes involved in os-
teogenesis, osterix (Osx) and osteocalcin (Ocn), was higher in the mutant mice in comparison
to wild-type mice (Fig 1E). Osteoclasts are cells that degrade bone to initiate normal bone re-
modeling and mediate bone loss in pathologic conditions and by increasing their resorptive ac-
tivity. Although osteoclast numbers were slightly reduced in femurs of knockout mice, the
reduction was not statistically significant, S3 Fig Together, the data collected from the femurs
suggest that the Spag17-mutant mice have enhanced bone formation, which may lead to bone
shortening due to premature ossification.
Spag17-deficient mice exhibit defects in tibia development. Measurement of tibia and
calcified bone length revealed a shorter distal limb on Spag17-mutant mice (Fig 2A). Morpho-
metric studies showed reduced growth plate area, characterized by a decrease in the number of
hypertrophic cells (terminally differentiated chondrocytes) (Fig 2B and S2 Fig). Also bone mor-
phology was affected by Spag17 disruption. Tibias had significantly less trabecular bone area, a
reduction in the relation of bone area/total area (BA/TA%) and an increased ratio of marrow
area/total area (MA/TA%) (Fig 2B). Calcification evaluation from von Kossa staining did not
show statistically significant differences between wild-type and Spag17-mutant mice (Fig 2C
and S2 Fig). However, micro-CT detected increased bone volume/total volume (BV/TV%) (Fig
2D). In addition, expression of Ocn and Osx was higher in the mutant mice in comparison to
wild-type mice (Fig 2E). No statistically significant differences in the osteoclast number were
observed in tibias comparing wild-type and knockout mice, S3 Fig These data suggest that the
effect of Spag17 in hind limb development depends on the maturation state of the individual
bones. Reduced Spag17 results in delayed tibial development. The shorter growth plate and the
presence of mainly primary bone might explain the shorter bone length compared to wild
type animals.
Spag17-deficient mice present fused sternebrae. Spag17-/- mice had additional skeletal
malformations. The sternum is a segmented structure (Fig 3A) consisting of the manubrium,
four sternebrae, and a xiphoid [20]. Micro-CT showed Spag17-/- mice had fused sternebrae fre-
quently (70%) between S3 and S4 and occasionally (20%) between S2, S3 and S4 (Fig 3C and S2
Video), but rarely (10%) between all sternebrae (Fig 3D and S3 Video). No fused sternebrae
were observed in wild-type mice. Sternebrae malformations were also observed by Alcian blue/
Alizarin red staining (Fig 3G). The failure of ribs 4, 5 and 6 to complete their attachment to the
sternum and promote sternebrae separation was apparent in the stained preparations in the
Spag17-/- mice. Similarly, histological examination showed failure of the last ribs to complete
their attachment to the sternum, leading fused sternebrae (Fig 3H).
Mineralization defects in skull and phalanges in Spag17-deficient mice. Micro-CT stud-
ies in Spag17-mutants showed separation in the bone from skull, which may be related to the
prominent hydrocephalous and the intracranial pressure (Fig 4A) [19]. In addition, there was
reduced mineralization in the skull (Fig 4B), suggesting membranous ossification defects. Me-
dial and metacarpal phalanges in Spag17-/- mice also showed reduced mineralization (Fig 4D
and 4E). To investigate defects in mineralization, osteoblasts were isolated from calvaria and
cultured using a standard protocol (see Materials and Methods), and alkaline phosphatase
Spag17 and Skeletal Development
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(ALP) activity, an early marker of osteoblast activity, was measured. Fig 4C shows a reduction
in ALP activity in Spag17-mutant mice.
Primary cilia are disrupted in Spag17-mutant mice
Cilia play important roles in proliferation, differentiation and functions of many cells. Ciliary
defects also results in skeletal development abnormalities [21]. Spag17 is expressed in tissues
with “9+2” motile cilia like testis, brain, oviduct, lung and trachea [14,19]. However, Spag17 ex-
pression in cartilage and bone has not been reported in mice. RT-PCR analysis on RNA isolat-
ed from articular cartilage and bone showed that this gene is indeed expressed in wild-type
mice, S4 Fig
In order to determine if primary cilia in bone and cartilage are affected in Spag17-mutant
mice, cultures of osteoblasts that were isolated from calvaria and cultures of chondrocytes that
were isolated from the costochondral cartilages from wild-type and Spag17-mutant mice were
Fig 2. Tibia bone development is affected in Spag17-deficient mice. (A) Alcian Blue/ Alizarin Red staining on tibia from wild-type (+/+) and Spag17-
mutant (-/-) mice. Measurement of tibia length and calcified tibia bone length shows Spag17-mutant limbs are shorter than wild-type mice. Scale bars, 0.5
mm. (B) Histological and morphometric studies on tibia shows cartilage and bone defects. Scale bars, 200 μm. (C) von Kossa staining. (D) Micro-CT
structural analysis on tibias; mid-sagittal sections (left) and cross-sectional trans-axial views at the mid-diaphysis (right). Images were acquired in 600
projections in 180 degrees of rotation with 500 miliseconds exposure per projection. Scale bars, 200 μm. (E) mRNA expression of osterix (Osx) and
osteocalcin (Ocn) measured by qPCR. (+/+), wild-type; (-/-), Spag17-mutant mice. Data are presented as means ± SEM from7 mice. * Indicates
statistically significant differences, p< 0.05. hz: hypertrophic zone; BA/TA: bone area/total area; MA/TA: marrow area/total area; BV/TV: bone volume/total
volume;Osx: osterix;Ocn: osteocalcin.
doi:10.1371/journal.pone.0125936.g002
Spag17 and Skeletal Development
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stained with anti-acetylated α-tubulin antibody (a primary cilia marker). Fig 5 shows that pri-
mary cilia from Spag17-/- mice are shorter than those from Spag17+/+ mice, and there is a re-
duction in the percentage of cells expressing primary cilia in the knockout cells.
To further evaluate an effect of Spag17 in primary cilia, mouse embryonic fibroblasts
(MEFs) were isolated from wild-type and Spag17-mutant embryos at E12.5. Expression of
SPAG17 in wild-type MEFs was shown by Western blot analysis (Fig 5E) using an anti-
SPAG17 antibody against the C-terminal domain. This antibody detected a protein ~ 75 kDa
molecular weight, suggesting that MEFs express a SPAG17 variant instead of the 250 kDa full
length protein [14,18]. This ~75 kDa protein may be derived from alternative splicing or post-
translational processing, processes [14]. SPAG17 mRNA was also detected in wild-type MEFs
by RT-PCR (Fig 5E). After serum-starvation to promote cilia growth, primary cilia were visual-
ized in the MEFs with anti-acetylated α-tubulin antibody. Primary cilia from Spag17-mutant
MEFs were significantly shorter than wild-type (Fig 5F). The same primary cilia phenotype
Fig 3. Disrupted development of the sternum in Spag17-/-mice. (A) Schematic representation of normal
sternal bones (M, manubrium; S1 to S4, sternebrae 1 to 4; X, xiphoid). (B,C and D) Analysis of the sternum by
micro-CT scanning shows fused sternebrae in the mutant mice. Pictures are representative images from
respective supporting videos. (Fig 3B is representative of S1 Video; Fig 3C is representative of S2 Video; and
Fig 3D is representative of S3 Video.) (E and G) Alcian blue/ Alizarin red staining. Failure of ribs 4, 5 and 6 to
complete their attachment to the sternum and promote sternebrae separation is apparent in the stained
preparations in the Spag17-/-mice (arrows). (F and H) Representative H&E staining shows the presence of
normal cartilage development that prevents fusion of the vertebrae in wild type animals. (+/+), wild-type; (-/-),
Spag17-mutant mice. * Fused sternebrae.
doi:10.1371/journal.pone.0125936.g003
Spag17 and Skeletal Development
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was reproduced by infecting wild-type MEFs with two different Spag17 siRNA duplex mole-
cules (Fig 5G).
Discussion
The embryonic limb is first visible as a small bud that protrudes from the body and contains
mesenchymal cells that are rounded by a layer of ectoderm. The limb skeleton is laid down pro-
gressively, starting from the proximal end to the distal end. The mesenchymal cells condense,
differentiate into cartilage, and later into bone. Many genes are known to regulate growth and
Fig 4. Cranial and phalanges defects in Spag17-/-. (A) Micro-CT imaging of mineralized skull. Note the demineralization of the skull in the mutant mouse
(white arrows). (B and E) Quantitative mineralization measurement by micro-CT scanning. (C) Alkaline phosphatase activity in cultured calvarial osteoblast.
(D) Micro-CT imaging of mineralized forelimb. Insert shows reduced metacarpal mineralization by Alcian Blue/ Alizarin Red staining. Micro-CT images were
acquired in 360 projections by 360 degree rotation, with 680 millisecond exposure per projection. White and black arrows indicate less metacarpal
mineralization in the mutant mouse. (+/+), wild-type; (-/-), Spag17-mutant mice. Data are presented as means ± SEM. * Indicates statistically significant
differences, p< 0.05.
doi:10.1371/journal.pone.0125936.g004
Spag17 and Skeletal Development
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patterning of the limb in three dimensions; however, is not to clear how these genes interact
[22]. The results showed here revealed an unexpected function of Spag17 gene in skeletal devel-
opment. It appears that mutation in Spag17 differentially altered femurs and tibias. Femurs
had mature Haversian bone formation, potentially leading to bone shortening due to prema-
ture ossification. Tibia bone shortening may be due to a delay in cartilage and primary bone
Fig 5. Primary cilia are altered in Spag17-deficient osteoblast, chondrocyte andMEFs cells.Cells were stained with anti-acetylated α-tubulin to
visualize primary cilia and DAPI as a nuclei marker. (A) Primary cilia length from osteoblast cells. Scale bars, 5 μm. (B) Percentage of osteoblast cells
expressing primary cilia. Scale bars, 20 μm (C) Primary cilia length from chondrocyte cells. Scale bars, 5 μm. (D) Percentage of chondrocyte cells expressing
primary cilia. Scale bars, 20 μm. Mouse embryonic fibroblasts (MEFs) were isolated from embryos at E12.5. (E) Detection of Spag17mRNA and protein in
MEFs. RT-PCR products were generated by primers from exon 4 and 5. The knockout mice have a deletion of the entire exon 5. Detection of SPAG17
protein by western blot using an antibody against C-terminal domain. (F) After serum-starvation to promote cilia growth, primary cilia were visualized in the
MEFs with acetylated tubulin antibody, and DAPI as a nuclei marker. Primary cilia from Spag17-mutant MEFs were significantly shorter than wild-type. Scale
bars, 5 μm. (G) Spag17 knockdown in WTMEFs cells after treatment with Spag17 siRNA duplex reproduced the shorter primary cilia phenotype. Scale bars,
5 μm. Arrows indicate primary cilia. (+/+), wild-type, (-/-); Spag17-mutant mice. Data are presented as means ± SEM. * Indicates statistically significant
differences, p< 0.05.
doi:10.1371/journal.pone.0125936.g005
Spag17 and Skeletal Development
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development. These results suggest defects in limb patterning and also chondrocyte and osteo-
blast differentiation and maturation.
It is not clear yet how SPAG17 influences bone development and mineralization, and how
its mutation can reduce and enhance this process in different bone locations as observed in
skull and phalanges and limbs from mutant mice, respectively. The site-specific differences in
the bone defects in Spag17-/- mice may be related to a location-specific cell signaling process.
Whether these are a consequence of inherent differences in development or are the cause of dif-
ferences in development is not clear. We have observed differential effects of gene deficiency in
the femur and tibia in other mice models due to the rate at which different bones in the embryo
develop [23]. The phenotypic changes in the femur of the Spag17-/- mice suggest increased
bone formation. In contrast, changes in the tibia, which matures at a later time than the femur,
indicate that the gene defect altered features of the growth plate. Similar developmentally relat-
ed changes were observed in sternum, where mineral was observed in the intersternebral spaces
at early times, when the presence of cartilage prevents fusion of the vertebrae in wild type ani-
mals. The observation that osteoclast number was not affected by Spag17 knockout may sug-
gest that the effect of Spag17 in bone and cartilage was on the anabolic phase (bone formation
and differentiation) and not on the remodeling phase. The effect of Spag17 on bone develop-
ment differentiation and calcification depends on the stage of bone maturation and the type of
bone. One potential reason why calvaria and long bones respond differentially to the lack of
this important cilia protein are their distinct functions, which lead to differences in the me-
chanical forces they undergo and to which the cilia are exposed.
Normal sternum development requires that all the ribs form a continuous bar of cartilage
between sternebrae by embryonic day 16 [20], suggesting that the defects in the Spag17-/- mice
may be due to alterations in early skeletal development. Fgfr1-mutant mice develop a similar
fused sternum phenotype as observed in Spag17-/- mice [24]. Additionally, Runx1 has been
shown to play an essential role in the development of the sternum [25], and Runx2 cooperates
with Runx1 during sternal morphogenesis [26]. However, the link between these genes and
their possible regulation by Spag17 remains to be clarified.
Mechanotransduction is a process that helps bone cells to convert mechanical forces into
biochemical signals. It is important for maintaining bone health and homeostasis [27]. Primary
cilia extend from the surface of cells and function mainly as sensory antenna [28]. This organ-
elle is believed to play a role in bone mechanotransduction [27]. In this context, calcium depo-
sition by osteoblasts has been shown to be mediated by primary cilia [29]. Cultures of MLO-A5
cells (murine long osteocyte cell line A5), which display shorter and fewer cilia per cell, show
reduced mineralization [29]. The same phenotype was observed in calvarial osteoblasts from
Spag17-mutant mice suggesting this may be one of the mechanisms where Spag17 plays a role
and has an effect in bone mineralization. In addition, several cell signaling pathways take place
in primary cilia development and function. For instances, vesicular trafficking, intraflagellar
transport (IFT), Hedgehog (Hh) and Wnt signaling converge in the organization and function-
al maintenance of the primary cilium [30,31]. Similar pathways influence cartilage and bone
development and growth [32]. Ciliary chondrodysplasias are believed to result from imbal-
ances in the signaling pathways that normally occur in functional cilia. Moreover, several
knockout mouse models for genes related to primary cilia made important contribution to the
knowledge of skeletal development [33].
Our understanding of how disruption of the Spag17 gene leads to alterations in primary
cilia function and subsequent cellular pathology is limited. It is unknown, if this CPC protein is
related to a structural function, as primary cilium lack the CPC, or it may plays a role in any of
the signaling (vesicular trafficking, intraflagellar transport (IFT), Hedgehog (Hh), Wnt signal-
ing, etc). Our results show that primary cilia are shorter in knockout mice. We hypothesize
Spag17 and Skeletal Development
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that Spag17may be involved in ciliogenesis like Spag6 [34], although its role and/or mecha-
nisms related to ciliogenesis may be different from Spag6. In addition, a ~75 kDa SPAG17 pro-
tein is expressed in MEFs suggesting that it is a variant instead of the 250 kDa full length
protein. This ~75 kDa protein may be derived from alternative splicing or post-translational
processing, processes. Further studies are required to determine how this protein functions in
primary cilia.
Several studies have reported an association of SPAG17 gene variants with height [1,7,9–
13]. However, until now there has been no known link between this gene, whose function was
thought to be restricted to motile cilia, and height. Our findings have revealed functions for
Spag17 that extend the role of this gene to regulation of skeletal differentiation, growth and
mineralization, perhaps because of a function in primary cilia. This newly defined role could
explain the influence of SPAG17 on linear growth and bone development.
Materials and Methods
Mice
All animal procedures were performed in accordance with the National Research Council’s
Guide for the Care and Use of Laboratory Animals. Animals were euthanized in accordance
with protocol AD10000167 approved by the Virginia Commonwealth University Institutional
Animal Care and Use Committee. Target disruption of Spag17 was made by deletion of exon 5
using Cre-lox and FLP-FRT recombination system. Briefly, embryonic stem (ES) cells were ob-
tained from the KOMP Repository (Davis, CA). The chimera males were crossed to C57BL/6J
wild-type females, the resulting heterozygous offspring were crossed to the 129S4/SvJaeSor-Gt
(ROSA)26Sortm1(FLP1)Dym/J to remove the Neo cassette. The Spag17+/flox mice were used for
mating with CMV-Cre (B6.C-Tg(CMV-cre)1Cgn/J) mice to generate Spag17+/-;CMV-Cremice.
Male and female Spag17+/-;CMV-Cremice were mated resulting in the expecting Mendelian in-
heritance for Spag17-/-;CMV-Cremice. After these mattings the mice had a mixed background
of C57BL/6J−129S4/SvJ. Deletion of this gene was published in detail in Teves et al., 2013 [19].
Histology studies
Bones were removed from newborn mice and fixed overnight in 4% formalin/PBS, dehydrated
in ethanol and embedded in paraffin. Slides were stained with hematoxylin and eosin. Histolo-
gy preparations were performed at the VCUMassey Cancer Center Macromolecule Core Facil-
ity, Virginia Commonwealth University.
Morphometric studies
Histological sections were imaged (Zeiss AxioObserver, Germany) using a 20x objective. Carti-
lage (growth plate area, percent hypertrophic cells in the growth plate, percent resting zone
cells, height of hypertrophic region, number of cells in hypertrophic region) and bone (total
bone area, cortical bone area, trabecular bone area, bone area/total area, and marrow area/total
area) were measured in the tibia and femur using Zen Black software (Zeiss). Data presented
are mean ± standard error of n = 7 mice. Osteoclast number was counted in 8 knockout and
Wild-type mice. Statistical comparisons were made using unpaired t-test; p< 0.05 was
considered significant.
High resolution micro-CT
Newly born mouse pups were euthanized using isoflurane, and the hindlimb and sternum were
removed and fixed in 10% neutral buffered formalin. High resolution microcomputed
Spag17 and Skeletal Development
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tomography (micro-CT) was performed using the Brϋker Skyscan 1173 micro-CT scanner
(Skyscan NV, Kontich, Belgium). Sternal and hind limb images were acquired in 600 projec-
tions in 180 degrees of rotation, with 500 millisecond exposure per projection, at 50 kilovolts
and 160 microamps, an image pixel size of 7.91 micrometers, and a rotation step of 0.40 de-
grees. Images were acquired at a resolution of 2240 x 2240 pixels. Sample images were recon-
structed standard Feldkamp reconstruction using NRecon Software (Kontich, Belgium) and a
Gaussian smoothing kernel of 2. Region of Interest (ROI) analysis was conducted using CT-
analysis software (CTAn, version 1.13.11.0, Skyscan NV) to assess the amount of attenuated
tissue present as a percentage of the total three dimensional volume in the ROI (% Bone Vol-
ume/Total Volume, %BV/TV). Data are mean ± standard error of n = 7 mice and statistical
comparisons were made using unpaired t-test; p< 0.05 was considered significant.
Measurement of bone length and width
Alcian blue/ Alizarin red stained hind limbs were scanned with Life Technologies EVOS Fl
Auto Cell Imagining System. Then images were analyzed, and bone measured by ImageJ soft-
ware (NIH). Data are mean ± standard error of n = 9 mice and statistical comparisons were
made using t-test; p< 0.05 was considered significant.
RT-PCR and qPCR
Total RNA was isolated with TRIzol (Life Technologies, Inc., Grand Island, N.Y.) from new-
born mice sternum, cartilage, and bone tissue. The RNA was reversed transcribed with RET-
ROscript kit (Ambion, Austin, TX) according to the manufacturer’s instructions, and the
cDNA were used for RT-PCR or qPCR. Amplification products were resolved on 1% agarose
gels stained with ethidium bromide. The results presented are representative of seven different
animals from each genotype shown.
Micro-CT scanning
Mouse pups were euthanized with excess of isoflurane and were then imaged in the micro-CT
scanner. Micro-CT was performed using an Inveon micro-CT system (Siemens, USA). Three
dimensional images were acquired in 360 projections by 360 degree rotation, with 680 millisec-
ond exposure per projection, around a 31 x 31 mm field of view (FOV), with 75 kV voltage,
500 μA of current and 2 × 2 binning were used to yield an effective pixel size of 19.24 μm and a
scan time of 6 minutes. A thin walled plastic tube containing water was scanned using the same
parameters and was used for Hounsfield unit (HU) normalization. HU normalized micro-CT
images were reconstructed using a modified Feldkamp algorithm using manufacturer provided
software (COBRA Exiim). ROI analyses for bone density and bone length measurements were
done in the Inveon Research Workplace 4.1 (Siemens Healthcare, PA). Statistical comparisons
were made using Student’s t-test; p< 0.05 was considered significant.
Alcian blue/ Alizarin red staining
Skeletons from newborn mice were stained with Alcian Blue/ Alizarin Red as described by Ovchin-
nikov D [35]. Skeletal preparations were analyzed and photographed in glycerol/ethanol solution.
von Kossa staining
Bones were removed from newborn mice and fixed overnight in 4% formalin/PBS, dehydrated
in ethanol and embedded in paraffin. Slides were stained for phosphate via the method of von
Kossa at the VCUMassey Cancer Center Macromolecule Core Facility, Virginia Commonwealth
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University using a kit and following manufacturer’s instructions (AmericanMasterTech Scientif-
ic Inc., CA, USA).
Osteoblast and chondrocyte isolation and culture
Newborn mice were euthanized by an overdose of isoflurane. Chondrocytes were isolated from
the costochondral cartilage following methods previously described for chondrocyte isolation
for rats [36]. Briefly, rib cages were removed and resting zone cartilage dissected. Cartilage
pieces were washed in Hank's Balanced Salt Solution (HBSS), incubated in 0.25% trypsin-
EDTA (Life Technologies) for 15 minutes, then in 0.02% collagenase type II (Worthington Bio-
chemicals, Freehold, NJ) for 3 hours. Cells were separated from tissue debris using 40 μm cell
strainers (BD, Franklin Lakes, NJ) and collected by centrifugation. Cells were cultured in
DMEM supplemented with 10% fetal bovine serum (FBS, Life Technologies), 1% penicillin-
streptomycin, and 50 ug/ml ascorbic acid (Sigma Aldrich). Osteoblasts were isolated from
frontal and parietal bones as previously described [37]. Briefly, minced bone pieces were di-
gested in trypsin followed by 0.01% collagenase type I (Sigma Aldrich) and 0.01% dispase (Life
Technologies). Cells were separated from debris using cell strainers and collected by centrifuga-
tion. Cells were cultured in DMEM supplemented with 10% FBS and 1% penicillin-streptomy-
cin. Passage one chondrocytes and osteoblasts were used for subsequent experiments.
MEFs isolation and culture
Mouse embryonic fibroblasts were isolated from E12.5 embryos. Head and heart tissues were
removed, and the remaining embryos were digested with 0.25% trypsin/EDTA at 37°C for 15
min. After digestion and removal of undigested tissues, the cells were plated into a 100 mm
dish, and allowed to grow in DMEM + 10% FBS. Early passages cells were used for all the ex-
periments. Spag17 was knocked down in WTMEFs by treatment with Spag17 (mouse) -3
unique 27mer siRNA duplex (OriGene Technologies, Inc. Rockville, MD).
Alkaline phosphatase activity
The assay was performed following standard techniques. Briefly, confluent cultures of mouse
osteoblasts were lysed in 0.05% Triton X-100 (Sigma Aldrich) and homogenized by sonication
for 10 seconds. Alkaline phosphatase specific activity was measured in the cell lysates as the re-
lease of p-nitrophenol from p-nitrophenylphosphate at pH 10.2. Enzyme activity was normal-
ized to total protein content of the lysates (BCA Assay, ThermoFisher).
Immunofluorescence studies
Osteoblasts and chondrocytes in passage one were fixed in 4% formalin for 1 hour at room
temperature and blocked with 10% goat serum diluted in PBS containing 3% BSA and 0.2%
Triton X-100. Then, cells were incubated with anti-acetylated α-tubulin mouse antibody over-
night at 4°C. After several washes in PBS, cells were stained with anti-mouse IgG alexa-488 la-
beled antibody (dilution 1: 3,000). Finally, slides were sealed using VectaMount with DAPI
(Vector Laboratories, Burlingame, CA). Images were taken by confocal laser-scanning micros-
copy (Leica TCS-SP2 AOBS). The same immunofluorescence staining protocol was used for
MEFs cells. The results presented are representative of mean ± standard error obtained from
four different animals of each genotype. Statistical comparisons were made using t-test;
p< 0.05 was considered significant.
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Western Blot
Equal amounts of protein (100 μg/lane) were heated to 95°C for 10 min in sample buffer, load-
ed onto 12% SDS-PAGE gels, electrophoretically separated, and transferred to PVDF mem-
branes (Millipore, Billerica, MA) by semi-dry transference. A dual-color precision plus protein
standard (BIO-RAD, Hercules, CA) was used. Membranes were blocked for 1 h in 5% milk-
TTBS (BIO-RAD, Hercules, CA) and then incubated overnight with Anti- SPAG17 C-terminal
antibody (1:5,000) at 4°C, After several washes in TTBS, the membranes were incubated with
an anti-rabbit IgG horseradish-peroxidase labeled antibody (1:2,000 dilution) for 1 h at room
temperature. Protein was detected with Super Signal Chemiluminescent Substrate (Pierce). β-
actin antibody was used as loading control to assure relatively equivalent amounts of protein
were present amongst sample types.
Statistical Analysis
InfoStat software was used for statistical analyses (Di Rienzo J.A., Casanoves F., Balzarini M.G.,
Gonzalez L., Tablada M., Robledo C.W. InfoStat ver 2009. Group InfoStat, FCA, Universidad
Nacional de Córdoba, Argentina). Data are presented as means ± standard error. Normality of
data was assessed by D'Agostino & Pearson omnibus normality test. Each set of data was ana-
lyzed comparing the means from two groups (wild-type and knockout) by Student’s t-test or
one-way analysis of variance (ANOVA) followed by Duncan’s test for three group compari-
sons. Samples were considered significantly different when the p-value was< 0.05.
Ethics statements
All animal procedures were performed in accordance with the National Research Council’s
Guide for the Care and Use of Laboratory Animals. Experiments were in accordance with pro-
tocol AD10000167 approved by the Virginia Commonwealth University Institutional Animal
Care and Use Committee.
Supporting Information
S1 Fig. Femur bone development is affected in Spag17-deficient mice. (A) Representative
high magnification pictures from H&E staining on femur from wild-type (+/+) and knockout
(-/-) mice. (B) Representative high magnification pictures from von Kossa staining on femur
from wild-type (+/+) and knockout (-/-) mice.
(TIF)
S2 Fig. Tibia bone development is affected in Spag17-deficient mice. (A) Representative
high magnification pictures from H&E staining on tibia from wild-type (+/+) and knockout
(-/-) mice. (B) Representative high magnification pictures from von Kossa staining on tibia
from wild-type (+/+) and knockout (-/-) mice.
(TIFF)
S3 Fig. Osteoclasts number is not statistically different in wild-type and Spag17-mutant
mice. (A) Osteoclasts number in femur from wild-type (+/+) and knockout (-/-) mice. (B) Os-
teoclasts number in tibia from wild-type (+/+) and knockout (-/-) mice. Data are presented as
means ± SEM from 8 mice for each group. No statistically significant differences were found
between the two groups, p> 0.05.
(TIFF)
S4 Fig. Spag17 expression in the skeleton. RT-PCR products generated by primers from exon
4 and 5. Notice the knockout mice have a deletion in the entire exon 5 [19]. RNA was isolated
Spag17 and Skeletal Development
PLOS ONE | DOI:10.1371/journal.pone.0125936 May 27, 2015 13 / 16
from wild-type and Spag17-mutant sternum (S), limb bone (B) and cartilage (C).
(TIF)
S1 Video. Analysis of the sternum by micro-CT scanning from Spag17+/+ (+/+) mouse.
(MOV)
S2 Video. Analysis of the sternum by micro-CT scanning from Spag17-/- (-/-) mouse show-
ing fusion of vertebrae S2, S3 and S4.
(MOV)
S3 Video. Analysis of the sternum by micro-CT scanning from Spag17-/- (-/-) mouse show-
ing fusion of all vertebrae.
(MOV)
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